Akebia Therapeutics News and Activities

Presence

Akebia Therapeutics develops and sells medicines for kidney disease and related conditions. Its products and services include biopharmaceutical treatments and clinical development programs for patients, healthcare providers, and dialysis organizations.

Akebia Therapeutics products and services overview:

  • Kidney disease therapies
  • Anemia treatments
  • Rare disease drugs
  • Clinical development
  • Drug licensing

Revenue: ~$185 million

Employees: 300

Headquarters: Cambridge, United States (USA)


Akebia Therapeutics is one of the...

Akebia Therapeutics is a company listed under the stock ticker AKBA (US).

Executives

View the org chart displaying its 30 main executives

Most searched biographies at Akebia Therapeutics
Popular executive movements at Akebia Therapeutics
  • Philip Vickers has joined the company as Director  (posted on April 2 2026).

Create your alert
to follow the executive moves at Akebia Therapeutics.

Biotechnology

Akebia Therapeutics has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology
Popular contacts in Biotechnology

Learn more about the Biotechnology industry

News

Press releases by Akebia Therapeutics
Social media about Akebia Therapeutics

Get in Touch

Call Akebia Therapeutics at +1 617...

View the org chart

Register to receive your alert

Report an error

The best decision-maker directory

Companies

Companies

Discover the organization charts of your favorite companies.

Executives

Executives

Spot the influential executives using our search tools.

Alerts

Alerts

Receive notifications when executive positions change.

Customers

Real-time

Fuel your company's success with our real-time data.

Individual Access Data & API
Executives
Companies
The Official Board